Cargando…
Assessing and reporting heterogeneity in treatment effects in clinical trials: a proposal
Mounting evidence suggests that there is frequently considerable variation in the risk of the outcome of interest in clinical trial populations. These differences in risk will often cause clinically important heterogeneity in treatment effects (HTE) across the trial population, such that the balance...
Autores principales: | Kent, David M, Rothwell, Peter M, Ioannidis, John PA, Altman, Doug G, Hayward, Rodney A |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2928211/ https://www.ncbi.nlm.nih.gov/pubmed/20704705 http://dx.doi.org/10.1186/1745-6215-11-85 |
Ejemplares similares
-
Competing risk and heterogeneity of treatment effect in clinical trials
por: Kent, David M, et al.
Publicado: (2008) -
Guidance to best tools and practices for systematic reviews
por: Kolaski, Kat, et al.
Publicado: (2023) -
Monitoring adverse social and medical events in public health trials: assessing predictors and interpretation against a proposed model of adverse event reporting
por: Moody, Gwenllian, et al.
Publicado: (2019) -
DELTA(2) guidance on choosing the target difference and undertaking and reporting the sample size calculation for a randomised controlled trial
por: Cook, Jonathan A., et al.
Publicado: (2018) -
Making randomised trials more efficient: report of the first meeting to discuss the Trial Forge platform
por: Treweek, Shaun, et al.
Publicado: (2015)